China SXT Pharmaceuticals, Inc. (SXTC)
NASDAQ: SXTC · IEX Real-Time Price · USD
1.090
0.00 (0.00%)
At close: Jul 19, 2024, 4:00 PM
1.110
+0.020 (1.83%)
Pre-market: Jul 22, 2024, 8:49 AM EDT
China SXT Pharmaceuticals Employees
China SXT Pharmaceuticals had 78 employees as of March 31, 2023. The number of employees decreased by 10 or -11.36% compared to the previous year.
Employees
78
Change (1Y)
-10
Growth (1Y)
-11.36%
Revenue / Employee
$384
Profits / Employee
-$181,235
Market Cap
793.36K
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2023 | 78 | -10 | -11.36% |
| Mar 31, 2022 | 88 | -8 | -8.33% |
| Mar 31, 2021 | 96 | -1 | -1.03% |
| Mar 31, 2020 | 97 | 1 | 1.04% |
| Mar 31, 2019 | 96 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| LogicMark | 27 |
| Biodexa Pharmaceuticals | 21 |
| Bluejay Diagnostics | 10 |
| Dermata Therapeutics | 8 |
| GRI Bio | 4 |
| Bone Biologics | 2 |
| Salarius Pharmaceuticals | 2 |
SXTC News
- 9 months ago - China SXT Pharmaceuticals, Inc. Regained Compliance with Nasdaq's Minimum Bid Price Rule - GlobeNewsWire
- 10 months ago - China SXT Pharmaceuticals Announces One-for-Twenty-five Reverse Stock Split - GlobeNewsWire
- 2 years ago - China SXT Pharmaceuticals, Inc. Announces 1 for 20 Reverse Share Split - GlobeNewsWire
- 2 years ago - China SXT Pharmaceuticals, Inc. Enters into Securities Purchase Agreement to Issue a 6% Convertible Promissory Note in the Original Principal Amount of $2.8 Million - GlobeNewsWire
- 2 years ago - Aegis Capital Corp. Acted as Sole Bookrunner on a $4.1 Million Underwritten Public Offering of Ordinary Shares, Inclusive of the Over-Allotment, for China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC). - Accesswire
- 2 years ago - China SXT Pharmaceuticals, Inc. Announces Successful Closing of $4.1 Million Follow-on Underwritten Offering of Ordinary Shares and Pre-Funded Warrants With Simultaneous Exercise of the Over-Allotment - GlobeNewsWire
- 2 years ago - China SXT Pharmaceuticals, Inc. Prices $3.5 Million Underwritten Public Offering of Ordinary Shares and Pre-Funded Warrants to Purchase Ordinary Shares - GlobeNewsWire
- 2 years ago - China SXT Pharmaceuticals, Inc. Announces Proposed Underwritten Public Offering of Ordinary Shares and Pre-Funded Warrants to Purchase Ordinary Shares - GlobeNewsWire